Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015, Article ID 164280, 6 pages
http://dx.doi.org/10.1155/2015/164280
Case Report

False Positive Radioiodinated Metaiodobenzylguanidine (123I-MIBG) Uptake in Undifferentiated Adrenal Malignant Tumor

1Department of Internal Medicine, College of Medicine, Inje University, Busan 614-735, Republic of Korea
2Department of Nuclear Medicine, Busan Paik Hospital, College of Medicine, Inje University, Busan 614-735, Republic of Korea
3Department of Pathology, Busan Paik Hospital, College of Medicine, Inje University, Busan 614-735, Republic of Korea
4Department of Radiology, Busan Paik Hospital, College of Medicine, Inje University, Busan 614-735, Republic of Korea
5Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Inje University, Busan 614-735, Republic of Korea

Received 27 January 2015; Accepted 19 March 2015

Academic Editor: Cesar V. Reyes

Copyright © 2015 Hee Soo Jung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. K. Wong, R. T. Waterfield, M. C. Marzola et al., “Contemporary nuclear medicine imaging of neuroendocrine tumours,” Clinical Radiology, vol. 67, no. 11, pp. 1035–1050, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. A. F. Jacobson, H. Deng, J. Lombard, H. J. Lessig, and R. R. Black, “123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 6, pp. 2596–2606, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Inoue, M. Akahane, T. Kitazawa et al., “False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma,” British Journal of Radiology, vol. 75, no. 894, pp. 548–551, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Rainis, S. Ben-Haim, and G. Dickstein, “False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 1, pp. 5–7, 2000. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Kume, S. Nishimura, S. Teramoto, A. Niimi, K. Tomita, and T. Kitamura, “An [123I]MIBG-positive malignant lymphoma involving the adrenal gland with hypercatecholaminaemia,” Clinical Radiology, vol. 63, no. 4, pp. 475–477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Sone, Y. Okuda, Y. Nakamura et al., “Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review,” Hormone Research, vol. 46, no. 3, pp. 138–142, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. J. L. Jameson and L. J. De Groot, “Pheochromocytoma,” in Endocrinology, chapter 109, pp. 1990–2018, Saunders, Philadelphia, Pa, USA, 6th edition, 2010. View at Google Scholar
  8. E. A. Mittendorf, D. B. Evans, J. E. Lee, and N. D. Perrier, “Pheochromocytoma: advances in genetics, diagnosis, localization, and treatment,” Hematology/Oncology Clinics of North America, vol. 21, no. 3, pp. 509–525, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Pacak, G. Eisenhofer, H. Ahlman et al., “Pheochromocytoma: recommendations for clinical practice from the First International Symposium,” Nature Clinical Practice Endocrinology and Metabolism, vol. 3, no. 2, pp. 92–102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. J. L. M. Timmers, A. Kozupa, G. Eisenhofer et al., “Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas,” Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 3, pp. 779–786, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ozkaya, M. F. Yuzbasioglu, E. Bulbuloglu et al., “Incidental pheochromocytoma presenting with sublaboratory findings in asymptomatic surrenal masses: a case report,” Cases Journal, vol. 1, no. 1, p. 10, 2008. View at Publisher · View at Google Scholar
  12. S. K. Kota, S. Panda, and K. D. Modi, “Pheochromocytoma: an uncommon presentation of an asymptomatic and biochemically silent adrenal incidentaloma,” Malaysian Journal of Medical Sciences, vol. 19, no. 2, pp. 86–91, 2012. View at Google Scholar · View at Scopus
  13. F. Lumachi, A. Tregnaghi, P. Zucchetta et al., “Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study,” Nuclear Medicine Communications, vol. 27, no. 7, pp. 583–587, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Zianni, M. Tzanela, S. Klimopoulos, and N. Thalassinos, “Symptomatic pheochromocytoma with normal urinary catecholamine metabolites,” Hormones, vol. 3, no. 2, pp. 132–137, 2004. View at Publisher · View at Google Scholar
  15. B. Shapiro and M. D. Gross, “Radiochemistry, biochemistry, and kinetics of 131I-metaiodobenzylguanidine (MIBG) and 123I-MIBG: clinical implications of the use of 123I-MIBG,” Medical and Pediatric Oncology, vol. 15, no. 4, pp. 170–177, 1987. View at Publisher · View at Google Scholar
  16. B. Shapiro, J. E. Copp, J. C. Sisson, P. L. Eyre, J. Wallis, and W. H. Beierwaltes, “Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases,” Journal of Nuclear Medicine, vol. 26, no. 6, pp. 576–585, 1985. View at Google Scholar · View at Scopus
  17. L. Kölby, P. Bernhardt, A.-M. Levin-Jakobsen et al., “Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters,” British Journal of Cancer, vol. 89, no. 7, pp. 1383–1388, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Rottenburger, E. Juettner, A. C. Harttrampf, M. Hentschel, U. Kontny, and J. Roessler, “False-positive radio-iodinated metaiodobenzylguanidine (123I-MIBG) accumulation in a mast cell-infiltrated infantile haemangioma,” British Journal of Radiology, vol. 83, no. 992, pp. e168–e171, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. M. Silverman, “Primary adrenal malignancy,” in Oncologic Imaging, chapter 21, pp. 359–376, Saunders, Philadelphia, Pa, USA, 2012. View at Google Scholar